Furthermore, the induction of clinically relevant driver mutations—TP53, PTEN and EGFR—in SVZ cells led to the development of brain tumours that were analogous to high-grade proliferative gliomas in 9/10 mouse models [2,180]. This evidence concerns the gene TP53 and central nervous system cancer.